Skip to content

A range of co-morbidities is associated with psoriasis, including metabolic

A range of co-morbidities is associated with psoriasis, including metabolic 1

A range of co-morbidities is associated with psoriasis, including metabolic diseases, such as diabetes, and psychological disorders. Although the systemic nature of psoriasis often remains unrecognized, the inflammatory processes involved may be associated with the development of co-morbidities, which, themselves, have a significant impact on the patient’s health and quality of life. Psoriasis has recently been shown to be associated with metabolic syndrome which is cluster of different comorbid conditions such as diabetes mellitus, hypertension, obesity and dyslipidemia, and a stronger predictor of cardiovascular diseases such as myocardial infarction. 5, 6 Major factors that may contribute to this unfavorable risk profile include cigarette smoking, alcoholism, obesity, physical inactivity, hyperhomocysteinemia, and psychological stress. Recently, it has been conceptualized that psoriasis is not merely a disease limited to skin and joints, rather it is a systemic inflammatory autoimmune disease that is connected with a range of co-morbidities. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. A range of co-morbidities is associated with psoriasis, including metabolic diseases, such as diabetes, and psychological disorders.

A range of co-morbidities is associated with psoriasis, including metabolic 2Psoriasis is associated with metabolic syndrome, which encompasses obesity, raised triglycerides, low high density lipoprotein (HDL), insulin resistance, and hypertension. III (ATPIII) criteria for the diagnosis of metabolic syndrome includes three or more of the following: triglyceride 150 mg/dl (1. 23, 24 The most common feature of the metabolic syndrome among patients with psoriasis was abdominal obesity, followed by hypertriglyceridemia and low levels of HDL cholesterol. HIV infection and AIDS – although other comorbid skin conditions may mimic psoriasis. Metabolic syndrome (abdominal obesity, hypertension, insulin resistance, dyslipidaemia). An assessment of any patient with psoriasis should include disease severity, the impact of disease on physical, psychological and social well-being, whether they have psoriatic arthritis, and the presence of any comorbidities. Psoriasis has been lately seen as a potential systemic inflammatory disease associated with a range of co-morbidities exhibiting an overlapping pathology and presenting a great social health impact such as cardiovascular disease and metabolic diseases, including obesity. Psoriasis has been lately seen as a potential systemic inflammatory disease associated with a range of co-morbidities exhibiting an overlapping pathology and presenting a great social health impact such as cardiovascular disease and metabolic diseases, including obesity. Adipocytokines could serve as a missing link in the association between psoriasis, obesity and metabolic co-morbidities.

Given the increased prevalence of cardiovascular co morbidities in patients, dermatologists treating psoriasis need to approach the disease as a potentially multisystem disorder and must alert these patients to the potentially negative effects of their disease. 1 There is an overwhelming data to substantiate that psoriasis is not just a disease of skin and joints but is a systemic, inflammatory autoimmune disease that is connected with a range of comorbidities such as Crohn’s disease, depression, sleep-apnoea, etc. Psoriasis is associated with comorbidities that include metabolic syndrome and increased cardiovascular risk.

Comorbidities In Psoriasis Aurangabadkar Sj

A range of co-morbidities is associated with psoriasis, including metabolic 3

Cardiovascular Comorbiditiy In Psoriasis Singh G, Aneja S